Evidence map›Paper›PMID 36364694›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Co-Treatment of Caco-2 Cells with Doxorubicin and Gold Nanoparticles Produced from

Jumoke A Aboyewa, Nicole R S Sibuyi, Mediline Goboza, Lee-Ann Murtz, Oluwafemi O Oguntibeju, Mervin Meyer

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jumoke A AboyewaPhytomedicine and Phytochemistry Group, Oxidative Stress Research Centre, Department of Biomedical Sciences, Cape Peninsula University of Technology, Bellville 7535, South Africa.
Nicole R S SibuyiDSI/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville 7530, South Africa.ORCID 0000-0001-7175-5388
Mediline GobozaDSI/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville 7530, South Africa.ORCID 0000-0003-1574-307X
Lee-Ann MurtzDSI/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville 7530, South Africa.ORCID 0000-0002-4485-5487
Oluwafemi O OguntibejuPhytomedicine and Phytochemistry Group, Oxidative Stress Research Centre, Department of Biomedical Sciences, Cape Peninsula University of Technology, Bellville 7535, South Africa.ORCID 0000-0002-7299-1128
Mervin MeyerDSI/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville 7530, South Africa.ORCID 0000-0002-8296-4860
Mintek · ZACape Peninsula University of Technology · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mangiferin (MGF) is a natural and valuable polyphenol found in significant levels in many plant species, including

Indexed as

apoptosisCyclopia intermediaDNA fragmentationgold nanoparticlesMangiferinmitochondrial depolarizationnanoparticle uptake

Identifiers

PMID36364694
PMCPMC9654788
OpenAlexW4308572918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.